Dr Reddy’s Lab Q2 net rises 26% to Rs 722 cr

Hyderabad : Aided by good sales growth coupled with new product launches, drug major Dr Reddy’s Laboratories reported a 25.74 % jump in consolidated net profit at Rs 721.89 crore for the second quarter ended September. Net income rose by 11% to Rs 3,988.96 crore during the quarter under review. “We had robust sales growth across our markets of US, India and Europe, supported by new products that were launched in the last twelve months,” Dr Reddy’s Laboratories co-chairman and CEO GV Prasad said.